Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 25, 855-858, July 1, 1965]
© 1965 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cividalli, G.
Right arrow Articles by Berenblum, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cividalli, G.
Right arrow Articles by Berenblum, I.

The Catabolism of Urethan in Young Mice of Varying Age and Strain, and in X-irradiated Mice, in Relation to Urethan Carcinogenesis1

G. Cividalli, S. S. Mirvish and I. Berenblum

( Department of Experimental Biology, The Weizmann Institute of Science, Rehovoth, Israel)

The rate of catabolism of urethan, which in newborn SWR mice is about 0.1 x the rate found in adults, was shown to increase slowly for the first 10 days after birth and most sharply between the 15th and 20th days. This factor appears to be critical in explaining the greater carcinogenic action of urethan in newborn and young mice.

Newborn mice of 4 other strains showed similar low rates of urethan catabolism, though they vary widely in their carcinogenic response to this drug. The rate of urethan catabolism was found to be the same in irradiated and nonirradiated mice, although the former are much more sensitive to urethan leukemogenesis. In these cases, therefore, other factors are responsible for the differences in carcinogenic response to urethan.

1 This work was supported in part by USPHS research grant CA-05263 from the National Cancer Institute.

Received 1/ 4/65.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1965 by the American Association for Cancer Research.